— Know what they know.
Not Investment Advice

ANIP NASDAQ

ANI Pharmaceuticals, Inc.
1W: +0.8% 1M: -5.9% 3M: -0.3% YTD: -0.1% 1Y: +17.4% 3Y: +51.6% 5Y: +139.7%
$81.04
+2.67 (+3.41%)
 
Weekly Expected Move ±3.8%
$72 $75 $78 $81 $83
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Sell · Power 46 · $1.8B mcap · 19M float · 1.75% daily turnover · Short 71% of daily vol
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$1.8B
52W Range62.61-99.5
Volume219,650
Avg Volume340,304
Beta0.43
Dividend
Analyst Ratings
7 Buy 3 Hold 0 Sell
Consensus Buy
Company Info
CEONikhil Lalwani
Employees970
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2000-05-05
210 Main Street West
Baudette, MN 56623
US
218 634 3500
About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Recent Insider Trades

NameTypeSharesPriceDate
Cook Meredith F-InKind 2,466 $79.20 2026-07-18
Cook Meredith S-Sale 500 $81.84 2026-07-13
CAREY STEPHEN P. M-Exempt 3,313 $49.51 2026-07-02
CAREY STEPHEN P. S-Sale 3,313 $86.00 2026-07-02
CAREY STEPHEN P. M-Exempt 3,313 $49.51 2026-07-02

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms